Uncovering Vaccine Adjuvants from Toll-like Receptor 4 Agonist

被引：0
|
作者：
Romaine, Marian [1 ]
机构：
[1] CUNY Hunter Coll, New York, NY USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
基金：
美国国家卫生研究院;
关键词：
Toll-like Receptor 4; Anti-inflammatory; phytochemical; vaccine adjuvants; Lipopolysaccharide;
D O I：
10.1016/j.jbc.2024.106024
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2030
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [31] Toll-like receptor 4 in atherosclerosis
    Li, Hongli
    Sun, Baogui
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (01) : 88 - 95
  • [32] Toll-like receptor 4 and atherogenesis
    Kiechl, S
    Wiedermann, CJ
    Willeit, J
    ANNALS OF MEDICINE, 2003, 35 (03) : 164 - 171
  • [33] Toll-like receptor 2 and Toll-like receptor 4 polymorphisms in invasive pneumococcal disease
    Moens, Leen
    Verhaegen, Jan
    Pierik, Marie
    Vermeire, Severine
    De Boeck, Kris
    Peetermans, Willy E.
    Bossuyt, Xavier
    MICROBES AND INFECTION, 2007, 9 (01) : 15 - 20
  • [34] Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells
    Spitzer, JH
    Visintin, A
    Mazzoni, A
    Kennedy, MN
    Segal, DM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (04) : 1182 - 1187
  • [35] Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion
    Lin, Yingzhong
    Feng, Tingmei
    Lan, Jiao
    Chen, Chunxia
    Qin, Zhiqiang
    Wu, Yanbin
    Shi, Huanzhong
    Ye, Jianbo
    Wei, Caizhou
    Wang, Wu
    Huang, Luying
    MEDICINAL CHEMISTRY, 2017, 13 (06) : 569 - 576
  • [36] Suppressive effects of toll-like receptor 2, toll-like receptor 4, and toll-like receptor 7 on protective responses to Mycobacterium bovis BCG from epithelial cells
    Singh, Aarti
    Singh, Akshita
    Saraswati, Shakuntala Surender Kumar
    Rana, Ankush Kumar
    Singh, Aayushi
    Verma, Chaitenya
    Sinha, Vishal
    Kalra, Kanika
    Natarajan, Krishnamurthy
    MICROBES AND INFECTION, 2025, 27 (02)
  • [37] Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy
    Johansen, P
    Senti, G
    Martinez Gomez, JM
    Storni, T
    Beust, BR
    Wüthrich, B
    Bot, A
    Kündig, TM
    CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (12): : 1591 - 1598
  • [38] Blocking CD13 in combination with a toll like receptor agonist increases the efficacy of cancer vaccine adjuvants
    Qendro, Veneta
    Ghosh, Mallika
    Shapiro, Linda
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [39] Transcriptomal signatures of vaccine adjuvants and accessory immunostimulation of sentinel cells by toll-like receptor 2/6 agonists
    Salyer, Alex C. D.
    David, Sunil A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (07) : 1686 - 1696
  • [40] Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
    Shanmugam, Arulkumaran
    Rajoria, Shilpi
    George, Andrea L.
    Mittelman, Abraham
    Suriano, Robert
    Tiwari, Raj K.
    PLOS ONE, 2012, 7 (02):
12345